Biomarkers in Cancer Detection and Monitoring of Therapeutics, Volume One, Discovery and Technologies discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancer types. This first volume in the series focuses on techniques and approaches recently developed to assist in the decision of which biomarker to use for specific conditions. Topics covered include circulating tumor cells and circulating tumor DNA, exomes, tumor microenvironment, gene editing, artificial intelligence and robotics. In…mehr
Biomarkers in Cancer Detection and Monitoring of Therapeutics, Volume One, Discovery and Technologies discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancer types. This first volume in the series focuses on techniques and approaches recently developed to assist in the decision of which biomarker to use for specific conditions. Topics covered include circulating tumor cells and circulating tumor DNA, exomes, tumor microenvironment, gene editing, artificial intelligence and robotics. In addition, the book discusses the development and applications of organoids and precision medicine.This book will be a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of biomarkers in cancer research.
1. CANCER BURDEN: EPIDEMIOLOGY, RACIAL AND GEOGRAPHICAL DISPARITIES Shaveta Menon and Ramila Bisht 2. MILESTONES IN CANCER RESEARCH Siddharth Sharma 3. TECHNOLOGICAL EVOLUTION IN CANCER DIAGNOSISAND THERAPEUTICS Sudeep Bose I 4. HOW DOES TIME SPEAK ABOUT CANCER, ITS DIAGNOSIS, TREATMENTS AND CHALLENGES? Asit Ranjan Ghosh 5. ROLE OF ARTIFICIAL INTELLIGENCE IN CANCER DIAGNOSTICS AND THERAPEUTICS B. Medhi 6. ADDRESSING THE DIAGNOSIS AND THERAPEUTICS OF MALIGNANT TUMOUR CELLS Anjoy Mahji 7. SOMATIC MUTATION: PHARMACOGENOMICS IN ONCOLOGY CARE Shamsher Singh 8. INSIGHTS INTO GENETIC PREDISPOSITION OF SOMATIC CANCERS B. Medhi 9. THE USE OF TUMOR MARKERS IN PROGNOSIS OF CANCER AND STRATEGIES TO PREVENT CANCER PREDISPOSITION AND PROGRESS Osama Ahmed, Mohamed Abd-Elbaset, Noha Ahmed and Eman Abd Elhaliem 10. CYTOGENETICS TO MULTI-OMICS IN BIOLOGY OF CANCER Sikander S. Gill 11. ROLE OF NON-CODING RNA AS BIOMARKERS FOR CANCER Bikash Medhi and B. Medhi 12. VIRAL miRNA's: DIAGNOSTIC AND PROGNOSTIC BIOMARKERS FOR CANCER AND INFECTIOUS DISEASE Sunil Babu Gosipatala, Dr. Abhishek Pandeya, Raj Kumar Khalko, Ranbir C. Sobti Sr., Sneha Kumari, Prashansa Khanna and Utkarsha Vishwakarma 13. PHARMACOGENOMICS AND ONCOLOGY: A THERAPEUTIC APPROACH FOR CANCER TREATMENT Shamsher Singh and Anil Kumar 14. ENVIRONMENTAL FACTORS INFLUENCING EPIGENETIC CHANGES INITIATING NEOPLASTIC CHANGES B. Medhi 15. OBESITY: EMERGING RISK FACTOR FOR CANCER BEYOND METABOLIC SYNDROME Ranbir C. Sobti Sr. 16. HOMOLOGOUS REPAIR DEFICIENCY AND PARP INHIBITORS IN CANCER MANAGEMENT Shivani Arora Mittal 17. MOLECULAR PROSPECTS OF TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES (TALENS) IN CANCER Mani Chopra 18. IMMUNO PEPTIDOMIC APPROACHES FORMANAGEMENT OFCANCER B. Medhi 19. REGULATION OF TUMOR MICROENVIRONMENT BY NUTRIENT TRAFFICKING B. Medhi 20. PRECISION MEDICINE : DOSE FOR ANTI CANCER THERAPY Dr Shiva Tushir
1. CANCER BURDEN: EPIDEMIOLOGY, RACIAL AND GEOGRAPHICAL DISPARITIES Shaveta Menon and Ramila Bisht 2. MILESTONES IN CANCER RESEARCH Siddharth Sharma 3. TECHNOLOGICAL EVOLUTION IN CANCER DIAGNOSISAND THERAPEUTICS Sudeep Bose I 4. HOW DOES TIME SPEAK ABOUT CANCER, ITS DIAGNOSIS, TREATMENTS AND CHALLENGES? Asit Ranjan Ghosh 5. ROLE OF ARTIFICIAL INTELLIGENCE IN CANCER DIAGNOSTICS AND THERAPEUTICS B. Medhi 6. ADDRESSING THE DIAGNOSIS AND THERAPEUTICS OF MALIGNANT TUMOUR CELLS Anjoy Mahji 7. SOMATIC MUTATION: PHARMACOGENOMICS IN ONCOLOGY CARE Shamsher Singh 8. INSIGHTS INTO GENETIC PREDISPOSITION OF SOMATIC CANCERS B. Medhi 9. THE USE OF TUMOR MARKERS IN PROGNOSIS OF CANCER AND STRATEGIES TO PREVENT CANCER PREDISPOSITION AND PROGRESS Osama Ahmed, Mohamed Abd-Elbaset, Noha Ahmed and Eman Abd Elhaliem 10. CYTOGENETICS TO MULTI-OMICS IN BIOLOGY OF CANCER Sikander S. Gill 11. ROLE OF NON-CODING RNA AS BIOMARKERS FOR CANCER Bikash Medhi and B. Medhi 12. VIRAL miRNA's: DIAGNOSTIC AND PROGNOSTIC BIOMARKERS FOR CANCER AND INFECTIOUS DISEASE Sunil Babu Gosipatala, Dr. Abhishek Pandeya, Raj Kumar Khalko, Ranbir C. Sobti Sr., Sneha Kumari, Prashansa Khanna and Utkarsha Vishwakarma 13. PHARMACOGENOMICS AND ONCOLOGY: A THERAPEUTIC APPROACH FOR CANCER TREATMENT Shamsher Singh and Anil Kumar 14. ENVIRONMENTAL FACTORS INFLUENCING EPIGENETIC CHANGES INITIATING NEOPLASTIC CHANGES B. Medhi 15. OBESITY: EMERGING RISK FACTOR FOR CANCER BEYOND METABOLIC SYNDROME Ranbir C. Sobti Sr. 16. HOMOLOGOUS REPAIR DEFICIENCY AND PARP INHIBITORS IN CANCER MANAGEMENT Shivani Arora Mittal 17. MOLECULAR PROSPECTS OF TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES (TALENS) IN CANCER Mani Chopra 18. IMMUNO PEPTIDOMIC APPROACHES FORMANAGEMENT OFCANCER B. Medhi 19. REGULATION OF TUMOR MICROENVIRONMENT BY NUTRIENT TRAFFICKING B. Medhi 20. PRECISION MEDICINE : DOSE FOR ANTI CANCER THERAPY Dr Shiva Tushir
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
